G. Pollack

G. M. Pollack, Xiaodong Yang, David S. Miller, 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Physiologic and metabolic influences on enterohepatic recirculation: Simulations based upon the disposition of valproic acid in the rat

Gary M. Pollack, Kim L. R. Brouwer, K. Brouwer, 1991, Journal of Pharmacokinetics and Biopharmaceutics.

Thermal Injury Decreases Hepatic Blood Flow and the Intrinsic Clearance of Indocyanine Green in the Rat

K. Brouwer, G. Pollack, 2004, Pharmaceutical Research.

Biliary excretion and enterohepatic recirculation of morphine-3-glucuronide in rats.

G. Pollack, D. Ouellet, 1995, Drug metabolism and disposition: the biological fate of chemicals.

Mechanisms Underlying Differences in Systemic Exposure of Structurally Similar Active Metabolites: Comparison of Two Preclinical Hepatic Models

K. Brouwer, J. Hall, M. Paine, 2011, Journal of Pharmacology and Experimental Therapeutics.

Central nervous system uptake kinetics of pentylenetetrazol in the developing rat

L. Haberer, G. Pollack, 1991, Biopharmaceutics & drug disposition.

Acute Valproic Acid Overdose

R. Dupuis, S. Lichtman, G. Pollack, 1990, Drug safety.

The development of morphine antinociceptive tolerance in nitric oxide synthase-deficient mice.

E. Heinzen, G. Pollack, 2004, Biochemical pharmacology.

Nonstationary disposition of valproic acid during prolonged intravenous infusion: contributions of unbound clearance and protein binding

G. Pollack, T. Arens, Tori L. Arens, 2001, Biopharmaceutics & drug disposition.

Pharmacodynamics of beta-blocker modulation of aqueous humor production.

K. Rittenhouse, G. Pollack, 2000, Experimental eye research.

Determination of hepatic blood flow in the rat using sequential infusions of indocyanine green or galactose.

K. Brouwer, K. Demby, J. A. Jones, 1990, Drug metabolism and disposition: the biological fate of chemicals.

Protein binding and hepatobiliary distribution of valproic acid and valproate glucuronide in rats.

K. Brouwer, E. Hall, G. Pollack, 1993, Biochemical pharmacology.

Increased brain P-glycoprotein in morphine tolerant rats.

K. Brouwer, C. Aquilante, G. M. Pollack, 1999, Life sciences.

Use of Plasma and Brain Unbound Fractions to Assess the Extent of Brain Distribution of 34 Drugs: Comparison of Unbound Concentration Ratios to in Vivo P-Glycoprotein Efflux Ratios

T. Maurer, J. C. Kalvass, G. Pollack, 2007, Drug Metabolism and Disposition.

Roles of innovation in education delivery.

Adam M Persky, Gary M Pollack, D. Beck, 2009, American journal of pharmaceutical education.

Drug transport at the blood-brain barrier and the choroid plexus.

C. L. Graff, G. Pollack, 2004, Current drug metabolism.

A pharmacokinetic model of inhaled methanol in humans and comparison to methanol disposition in mice and rats.

K. Ward, G. M. Pollack, R. Perkins, 1995, Environmental health perspectives.

Implementation and preliminary evaluation of an Honours-Satisfactory-Fail competency-based assessment model in a Doctor of Pharmacy programme

Brenda S. Bray, Jennifer D. Robinson, C. Remsberg, 2017 .

Physiologic pharmacokinetic modeling of gastrointestinal blood flow as a rate-limiting step in the oral absorption of digoxin: implications for patients with congestive heart failure receiving epoprostenol.

K. Brouwer, L. D. Carlton, G. Pollack, 1996, Journal of pharmaceutical sciences.

Use of an electrochemical nitric oxide sensor to detect neuronal nitric oxide production in conscious, unrestrained rats.

E. Heinzen, G. Pollack, 2002, Journal of pharmacological and toxicological methods.

Pharmacodynamics and tolerance development during multiple intravenous bolus morphine administration in rats.

G. M. Pollack, D. M. Ouellet, G. Pollack, 1997, The Journal of pharmacology and experimental therapeutics.

Influence of time to achieve substrate distribution equilibrium between brain tissue and blood on quantitation of the blood–brain barrier P-glycoprotein effect

G. M. Pollack, Jeannie M. Padowski, G. Pollack, 2011, Brain Research.

Assessment of Blood–Brain Barrier Permeability Using the In Situ Mouse Brain Perfusion Technique

G. M. Pollack, J. C. Kalvass, Rong Zhao, 2009, Pharmaceutical Research.

Sensitive analysis of [D-Pen2,5]enkephalin in rat serum by capillary electrophoresis and laser-induced fluorescence detection.

J. Jorgenson, M. A. Moseley, G. M. Pollack, 1997, Journal of chromatography. B, Biomedical sciences and applications.

Fexofenadine Brain Exposure and the Influence of Blood-Brain Barrier P-Glycoprotein After Fexofenadine and Terfenadine Administration

Gary M Pollack, J. C. Kalvass, Rong Zhao, 2009, Drug Metabolism and Disposition.

Fexofenadine Brain Exposure and the Influence of Blood-Brain Barrier P- glycoprotein Following Fexofenadine and Terfenadine Administration

G. M. Pollack, J. C. Kalvass, Rong Zhao, 2008 .

The influence of distributional kinetics into a peripheral compartment on the pharmacokinetics of substrate partitioning between blood and brain tissue

Jeannie M. Padowski, G. Pollack, 2011, Journal of Pharmacokinetics and Pharmacodynamics.

Chronic stress impairs oxidative metabolism and hepatic excretion of model xenobiotic substrates in the rat.

L. Haberer, J. Browne, J. Márton, 1991, Drug metabolism and disposition: the biological fate of chemicals.

Comparison of two cyclosporine formulations in healthy volunteers: bioequivalence of the new Sang-35 formulation and Neoral.

P. Pouletty, T. Schroeder, L. Moore, 1998, Journal of clinical pharmacology.

Altered disposition and antinociception of [D-penicillamine(2,5)] enkephalin in mdr1a-gene-deficient mice.

G. M. Pollack, C. Chen, G. Pollack, 1998, The Journal of pharmacology and experimental therapeutics.

Disposition and protein binding of valproic acid in the developing rat.

L. Haberer, G. Pollack, 1994, Drug metabolism and disposition: the biological fate of chemicals.

Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation.

Gary M Pollack, Jeannie M Padowski, Jeannie M. Padowski, 2010, Methods in molecular biology.

Extensive Biliary Excretion of the Model Opioid Peptide [D-PEN2,5] Enkephalin in Rats

Cuiping Chen, G. Pollack, 1997, Pharmaceutical Research.

Modelling the cardiovascular effects of ephedrine.

Adam M Persky, Kim L R Brouwer, Gary M Pollack, 2004, British journal of clinical pharmacology.

Kinetic Considerations for the Quantitative Assessment of Efflux Activity and Inhibition: Implications for Understanding and Predicting the Effects of Efflux Inhibition

G. M. Pollack, J. C. Kalvass, G. Pollack, 2007, Pharmaceutical Research.

Preparing for a Renaissance in pharmacy education: the need, opportunity, and capacity for change.

Gary M Pollack, R. Blouin, P. Joyner, 2008, American journal of pharmaceutical education.

Intestinal Absorptive Transport of the Hydrophilic Cation Ranitidine: A Kinetic Modeling Approach to Elucidate the Role of Uptake and Efflux Transporters and Paracellular vs. Transcellular Transport in Caco-2 Cells

G. M. Pollack, D. Thakker, D. Bourdet, 2006, Pharmaceutical Research.

Pharmacokinetics and Pharmacodynamics of Seven Opioids in P-Glycoprotein-Competent Mice: Assessment of Unbound Brain EC50,u and Correlation of in Vitro, Preclinical, and Clinical Data

D. Selley, G. M. Pollack, J. C. Kalvass, 2007, Journal of Pharmacology and Experimental Therapeutics.

Use of Loperamide as a Phenotypic Probe of mdr1a Status in CF-1 Mice

G. M. Pollack, J. C. Kalvass, C. L. Graff, 2004, Pharmaceutical Research.

Breast Cancer Resistance Protein Interacts with Various Compounds in Vitro, but Plays a Minor Role in Substrate Efflux at the Blood-Brain Barrier

Thomas J. Raub, G. M. Pollack, S. C. Kasper, 2009, Drug Metabolism and Disposition.

Toxicokinetics of intravenous methanol in the female rat.

K. Brouwer, J. Kawagoe, G. Pollack, 1993, Fundamental and Applied Toxicology.

Indirect Analysis of Nitric Oxide and Quantitation of Selective Nitric Oxide Synthase Inhibitors in Microdialysate Samples

G. Pollack, 2013 .

Effect of prior morphine-3-glucuronide exposure on morphine disposition and antinociception.

G. Pollack, D. Ouellet, 1997, Biochemical pharmacology.

A Modified Team-Based Learning Physiology Course

A. Persky, G. Pollack, 2011, American Journal of Pharmaceutical Education.

Transforming a Large-Class Lecture Course to a Smaller-Group Interactive Course

Adam M Persky, Gary M Pollack, A. Persky, 2010, American Journal of Pharmaceutical Education.

Blood-brain disposition and antinociceptive effects of -D-penicillamine2,5-enkephalin in the mouse.

C. Chen, G. Pollack, 1997, The Journal of pharmacology and experimental therapeutics.

Pharmacokinetics and Pharmacodynamics of Seven Opioids in P-Glycoprotein-Competent Mice: Assessment of Unbound Brain EC 50,u and Correlation of in Vitro, Preclinical, and Clinical Data

D. Selley, J. C. Kalvass, Emily R. Olson, 2007 .

Variable modulation of opioid brain uptake by P-glycoprotein in mice.

C. L. Graff, Claude Dagenais, G. Pollack, 2004, Biochemical pharmacology.

Assessment of Valproic Acid Serum–Cerebrospinal Fluid Transport by Microdialysis

P. L. Golden, K. Brouwer, G. Pollack, 1993, Pharmaceutical Research.

Development of an In Situ Mouse Brain Perfusion Model and its Application to mdr1a P-Glycoprotein-Deficient Mice

Christophe Rousselle, Gary M. Pollack, C. Rousselle, 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Regional differences in capillary density, perfusion rate, and P-glycoprotein activity: a quantitative analysis of regional drug exposure in the brain.

Gary M Pollack, Rong Zhao, Rong Zhao, 2009, Biochemical pharmacology.

Pharmacokinetic analysis of trichloroethylene metabolism in male B6C3F1 mice: Formation and disposition of trichloroacetic acid, dichloroacetic acid, S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine.

I. Rusyn, Sungkyoon Kim, L. Collins, 2009, Toxicology and applied pharmacology.

Pharmacokinetics of Substrate Uptake and Distribution in Murine Brain After Nasal Instillation

Gary M. Pollack, G. M. Pollack, C. L. Graff, 2005, Pharmaceutical Research.

Examination of the ability of the nasal administration route to confer a brain exposure advantage for three chemical inhibitors of P-glycoprotein.

G. M. Pollack, Jeannie M. Padowski, G. Pollack, 2010, Journal of pharmaceutical sciences.

Hepatobiliary Disposition of the Metabolically Stable Opioid Peptide [d-Pen2, d-Pen5]-Enkephalin (DPDPE): Pharmacokinetic Consequences of the Interplay between Multiple Transport Systems

K. Brouwer, K. Hoffmaster, M. Zamek-Gliszczynski, 2004, Journal of Pharmacology and Experimental Therapeutics.

DMD # 1420 R Multiple Transport Systems Mediate the Hepatic Uptake and Biliary Excretion of the Metabolically Stable Opioid Peptide [ D-penicillamine 2 , 5 ] enkephalin

Brouwer, K. Hoffmaster, R. Kiml, 2004 .